Prognostic Utility of Routine Chimerism Testing at 2 to 6 Months after Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 3, 2009, Pages 352-359

  Mossallam, Ghada I ^a   Kamel, Azza M ^a   Storer, Barry ^b,c   Martin, Paul J ^b,c  

^a CAIRO UNIVERSITY   (Egypt)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic hematopoietic cell transplantation; Chimerism analysis; Mixed chimerism

Indexed keywords

BUSULFAN; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL PRACTICE; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HLA MATCHING; HODGKIN DISEASE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MORTALITY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PROGNOSIS; RELAPSE; RISK ASSESSMENT; RISK REDUCTION; T LYMPHOCYTE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59349106821     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.12.496     Document Type: Article

References (19)

1. Antin J.H., Childs R., Filipovich A.H., et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 7 (2001) 473-485
2. Lion T. Detection of impending graft rejection and relapse by lineage-specific chimerism analysis. Methods Mol Med 134 (2007) 197-216
3. Lamba R., Abella E., Kukuruga D., et al. Mixed hematopoietic chimerism at day 90 following allogeneic myeloablative stem cell transplantation is a predictor of relapse and survival. Leukemia 18 (2004) 1681-1686
4. Doney K.C., Loken M.R., Bryant E.M., et al. Lack of utility of chimerism studies obtained 2-3 months after myeloablative hematopoietic cell transplantation for ALL. Bone Marrow Transplant 42 (2008) 271-274
5. Dewald G.W., Schad C.R., Christensen E.R., et al. Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite-sex transplantation. Bone Marrow Transplant 12 (1993) 149-154
6. Smith A.G., and Martin P.J. Analysis of amplified variable number tandem repeat loci for evaluation of engraftment after hematopoietic stem cell transplantation. Rev Immunogenet 1 (1999) 255-264
7. Thiede C., Bornhauser M., Oelschlagel U., et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem transplantation (BSCT) using multiplex PCR amplification of short tandem repeat markers. Leukemia 15 (2001) 293-302
8. Baron F., and Sandmaier B.M. Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning. Leukemia 20 (2006) 1690-1700
9. Mattsson J., Uzunel M., Remberger M., et al. Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation. Bone Marrow Transplant 32 (2003) 477-483
10. McCann S., Passweg J., Bacigalupo A., et al. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia. Bone Marrow Transplant 39 (2007) 109-114
11. Balon J., Hałaburda K., Bieniaszewska M., et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant 35 (2005) 1083-1088
12. van Leeuwen J.E., van Tol M.J., Joosten A.M., et al. Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood 83 (1994) 3059-3067
13. Mattsson J., Uzunel M., Tammik L., et al. Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation. Leukemia 15 (2001) 1976-1985
14. Boeck S., Hamann M., Pihusch V., et al. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplant 37 (2006) 57-64
15. Román J., Serrano J., Jiménez A., et al. Myeloid mixed chimerism is associated with relapse in bcr-abl-positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia. Haematologica 85 (2000) 173-180
16. Serrano J., Roman J., Sanchez J., et al. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse. Blood 95 (2000) 2659-2665
17. Mackinnon S., Barnett L., Heller G., et al. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 83 (1994) 3409-3416
18. Bader P., Beck J., Frey A., et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 21 (1998) 487-495
19. Martin P.J. Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' Hematopoietic Cell Transplantation (2008), Blackwell, Oxford, UK